# Stereotactic Ablative Radiation Therapy for Prostate Cancer

> **NCT05668351** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Medical University of South Carolina** · enrollment: 42 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **RADIATION:** SUPR-SABR treatment

## Key facts

- **NCT ID:** NCT05668351
- **Lead sponsor:** Medical University of South Carolina
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-05-12
- **Primary completion:** 2028-01-15
- **Final completion:** 2028-01-15
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2026-02-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05668351

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05668351, "Stereotactic Ablative Radiation Therapy for Prostate Cancer". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT05668351. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*